What's in Omar Mamdouh Shaaban's pipeline?

Omar Mamdouh Shaaban has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Omar Mamdouh Shaaban's portfolio?

Top competitors by shared drug class: Bayer, Baylor Research Institute, Bio Meds Pharmaceutica Ltda, Bristol-Myers Squibb, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/omar-mamdouh-shaaban.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Omar Mamdouh Shaaban — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Omar Mamdouh Shaaban pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
LMWH+Folic acid	LMWH+Folic acid	marketed	Anticoagulant combination with vitamin supplement	Factor Xa, Thrombin (LMWH component); Dihydrofolate reductase (folic acid component)	Cardiovascular / Hematology
Vaginal Progesteron	Vaginal Progesteron	marketed	Progestin	Progesterone receptor	Obstetrics/Gynecology

Therapeutic area mix

Cardiovascular / Hematology · 1
Obstetrics/Gynecology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Baylor Research Institute · 1 shared drug class
Bio Meds Pharmaceutica Ltda · 1 shared drug class
Bristol-Myers Squibb · 1 shared drug class
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 shared drug class
Exeltis Usa Inc · 1 shared drug class
Fdn Consumer · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Omar Mamdouh Shaaban:

Cite this brief

Drug Landscape (2026). Omar Mamdouh Shaaban — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/omar-mamdouh-shaaban. Accessed 2026-05-16.